Stable formulations of buprenorphine
AssigneeElanco US Inc.
InventorScott Hostetler
Life of this patent
Estimating the term…
Abstract
Methods of providing pain relief to animals, for example cats, by administering a formulation comprising buprenorphine or salt thereof are described. A formulation comprising buprenorphine or salt thereof and an additive selected from butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT) and combinations thereof and methods of storage and using such formulations are also provided.
Claims48
(canceled)
A method of treating pain in an animal in need thereof comprising transdermally administering a liquid pharmaceutical composition comprising a therapeutically effective amount of buprenorphine or salt thereof to the animal.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A formulation comprising buprenorphine or salt thereof, and at least one additive selected from the group comprising butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT) and combinations thereof.
Dependencies are inferred from the claim text.